Source: MONTANA STATE UNIVERSITY submitted to NRP
EXPRESSION OF MYELOID CELL ASSOCIATED GENES IN BOVINE GAMMA DELTA T CELLS
Sponsoring Institution
National Institute of Food and Agriculture
Project Status
COMPLETE
Funding Source
Reporting Frequency
Annual
Accession No.
0196932
Grant No.
2003-35204-13703
Cumulative Award Amt.
(N/A)
Proposal No.
2003-02483
Multistate No.
(N/A)
Project Start Date
Sep 1, 2003
Project End Date
Aug 31, 2007
Grant Year
2003
Program Code
[44.0]- (N/A)
Recipient Organization
MONTANA STATE UNIVERSITY
(N/A)
BOZEMAN,MT 59717
Performing Department
Immunology & Infectious Diseases
Non Technical Summary
Understanding the bovine immune system is critical to the development of improved vaccines and/or therapies for infection diseases. This project examines unique characteristics of the major lymphocyte subset in newborn calves. The intent of the study is to identify new approaches to the control of this cell to enhance responses against vaccines and/or therapuetic adjuvants.
Animal Health Component
10%
Research Effort Categories
Basic
90%
Applied
10%
Developmental
(N/A)
Classification

Knowledge Area (KA)Subject of Investigation (SOI)Field of Science (FOS)Percent
31534101090100%
Goals / Objectives
In contrast to in most animals, gamma/delta T cells represent a major lymphocyte subset in newborn calves and, as such, are likely of utmost importance to the health and wellbeing of cattle. In a recent genomic analysis of tissue-specific gamma/delta T cell subsets begun two years ago, we have identified totally unexpected gene expression profiles that predict functions and responses more in-line with myeloid than with lymphoid cells. These results suggest that controlling gamma/delta T cell function maybe accomplished by methods used to alter myeloid cell activity. In this proposal, we intend to test the hypothesis that bovine gamma/delta T cells express myeloid cell associated genes and the expression of these genes is associated with expression of myeloid cell restricted transcription factors. Three specific aims will be pursued: Specific Aim 1) examine expression of BLIMP-1, a master regulator of myeloid cell differentiation, in bovine gamm/delta T cells; Specific Aim 2) characterize toll-like receptor (TLR) function on bovine gamma/delta T cells; and Specific Aim 3) examine expression of myeloid cell surface antigens on resting and activated bovine gamma/delta T cells.
Project Methods
The first Aim will use a genetic approach for the characterization of a specific myeloid and B cell associated transcription factor (BLIMP-1) recently found to be expressed in bovine gamma/delta T cells. Real time RT-PCR, RNase protection assays, ectopic expression assays, and RNA interference technologies will be used to examine the expression and function of BLIMP-1 in bovine T cells. In the second Aim, real time RT-PCR, flow cytometry, and leukocyte migration assays will be used to define the potential function of toll-like receptors (TLRs) on bovine gamma/delta T cells. In the third Aim, functional assays for gap junction proteins, scavenger receptors, and LPS binding receptors will be used to characterize connexin 43, scavenger receptor 1 and 2, and CD14 on bovine gamma/delta T cells.

Progress 09/01/03 to 08/31/07

Outputs
OUTPUTS: This project was focused on the analysis of myeloid cell associated genes and their products in bovine gamma/delta T cells. We have performed a comprehensive analysis of over 20 myeloid cell genes in sorted bovine gamma/delta T cells. Transcripts were found for all TLRs, scavenger receptors, CD11b, and a number of other genes. We systematically examined the function of each of these gene products. We first showed that bovine gamma/delta T cells express functional CD36, which is regulated by phorbol ester activation. Gamma/delta T cell CD36 facilitates TLR2 recognition of LTA. We have also confirmed that gamma/delta T cells express NRAMP, NOD2 and the MARCO scavenger receptor, which are the focus of our current analyses. Analysis of the BLIMP-1 transcription factor, which is important in the differentiation of myeloid cells and B cells, is also being pursued in this project. In addition to the study of the regulation of Blimp-1 in bovine T cells, we have recently confirmed expression in human gamma/delta T cells. Using well defined molecular approaches available in the human system, we have now confirmed functional activity of gamma/delta T cell Blimp-1 in gel shift assays. Specifically, gamma/delta T cell Blimp-1 binds the human cIITA and cMYC Blimp-1 binding sites. The interaction is highly conserved, since bovine Blimp-1 also binds the same human promoters. Though not included in the original proposal, in the past year we have explored the use of nanotechnology to delivery antigens/agonists to bovine cells. Our current experiments are focused on delivering PAMPs via viral nanoparticles, as an approach to selectively stimulated bovine gd T cells. We have also recently tested a novel inhibitor of T cell signaling. A grant on NRAMP-1 in gamma/delta T cells was submitted in 2007. PARTICIPANTS: Mark Jutila served as PI on this project. Jill Graff completed her MS dissertation work on this project and then moved into a Research Associate position. She led most of the work done on this project. Kirk Lubick worked as a MAES funded research associate on this project. Edward Schmidt was a collaborator who worked closely with Ms Graff on the transcription factor studies on this project. Jodi Hedges worked a short time on this project as a postdoc. A number of undergraduate students spent short periods of time on this project.

Impacts
This series of experiments has shed light on common gene expression patterns in bovine myeloid cells and gamma/delta T cells. Identifying and characterizing funtional myeloid cell gene products in gamma/delta T cells may lead to the development of novel approaches to control the activity of these cells.

Publications

  • Uchida, M., Flenniken, M., Allen, M., Willits, D.A., Crowley, B.E., Brumfield, S., Willis, A.F., Jackiw-Turk, L., Jutila, M., Young, M. and Douglas, T. 2006. Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles. J. Amer. Chem. Soc.,128:16626.
  • Kaiser, C.R., Flenniken, M., Gillitzer, E., Harmsen, A.L., Harmsen, A. G., Jutila, M.A., Douglas, T.,and Young, M.J. 2007. Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance in vivo. Intern. J. Nanomedicine, 2: 715.
  • Jutila, M.A., Holderness, J., Graff, J., and Hedges, J.F. 2008. Antigen independent priming: A transitional response of bovine gd T cells to infection. Animal Health Research Reports, in press.
  • Ren, Y., Strobel, G., Graff, J., Jutila, M., Park, S.G., Gosh, S., Teplow, D., Condron, M., Pang, E., and Hess, W.M. 2007. Volutellin A, an immunosuppressive peptide from Volutella sps,. Microbiology, in press.


Progress 01/01/06 to 12/31/06

Outputs
This project is focused on the analysis of myeloid cell associated genes and their products in bovine gamma/delta T cells. We have performed a comprehensive analysis of over 20 myeloid cell genes in sorted bovine gamma/delta T cells. Transcripts were found for all TLRs, scavenger receptors, CD11b, and a number of other genes. We have started to systematically examine the function of each of these gene products. We first showed that bovine gamma/delta T cells express functional CD36, which is regulated by phorbol ester activation. We have now found that certain TLR agonists will also regulate CD36 on gamma/delta T cells. Gamma/delta T cell CD36 facilitates TLR2 recognition of LTA. We have also confirmed that gamma/delta T cells express NRAMP, NOD2 and the MARCO scavenger receptor,which are the focus of our current analyses. In the past year, we showed that bovine gamma/delta T cells respond to the NOD2 agonist, muramyl dipeptide. The NOD2 response leads to priming of the gamma/delta T cells, which greatly increases downstream proliferative responses to IL-2 and IL-15. We recently have started an analysis of CD11b on gamma/delta T cells in which we have shown its regulation in response to plant polyphenols is opposite to the regulation of CD11b on monocytes. Our detailed functional analysis of BLIMP-1 suggest that it may function in a unique fashion in gamma/delta T cells, in that we have now confirmed its expression is upregulated at a period o time in which gamma/delta T cells are actively proliferating in response to IL-2. This was not expected, since the literature shows BLIMP-1 to be a repressor of proliferation.

Impacts
This series of experiments will shed light on common gene expression patterns in bovine myeloid cells and gamma/delta T cells. Indentifying and characterizing funtional myeloid cell gene products in gamma/delta T cells may lead to the development of novel approaches to control the activity of these cells

Publications

  • Hedges, J.F., Kerns, M.M., and Jutila, M.A. 2006. The distinct responses of gd T cells to the Nod2 agonist, muramyl dipeptide. Submitted


Progress 01/01/05 to 12/31/05

Outputs
This project is focused on the analysis of myeloid cell associated genes and their products in bovine gamma/delta T cells. We have performed a comprehensive analysis of over 20 myeloid cell genes in sorted bovine gamma/delta T cells. Transcripts were found for all TLRs, scavenger receptors, CD11b, and a number of other genes. We have started to systematically examine the function of each of these gene products. We first showed that bovine gamma/delta T cells express functional CD36, which is regulated by phorbol ester activation. Gamma/delta T cell CD36 facilitates TLR2 recognition of LTA. We have also confirmed that gamma/delta T cells express NRAMP, NOD2 and the MARCO scavenger receptor,which are the focus of our current analyses. Analysis of the BLIMP-1 transcription factor, which is important in the differentiation of myeloid cells and B cells, is also being pursued in this project. In addition to the study of the regulation of Blimp-1 in bovine T cells, we have recently confirmed expression in human gamma/delta T cells. Using well defined molecular approaches available in the human system, we have now confirmed functional activity of gamma/delta T cell Blimp-1 in gel shift assays. Specifically, gamma/delta T cell Blimp-1 binds the human cIITA and cMYC Blimp-1 binding sites.

Impacts
This series of experiments will shed light on common gene expression patterns in bovine myeloid cells and gamma/delta T cells. Indentifying and characterizing funtional myeloid cell gene products in gamma/delta T cells may lead to the development of novel approaches to control the activity of these cells.

Publications

  • Lubick, K and Jutila, M.A.. 2005. LTA Recognition by Bovine gamma/delta T cells Involves CD36. Journal of Leukocyte Biology, in press.
  • Graff, JC, MA Jutila. 2005. Identification of functional B lymphocyte induced maturation protein-1 (BLIMP-1) in gd T cells. FASEB J. (Abstract) 46.33.
  • Hedges, JF, and MA Jutila. 2005. Response of gammadelta T cells to the NOD2 agonist muramyl dipeptide. FASEB J. (Abstract) 826.15.


Progress 01/01/04 to 12/31/04

Outputs
This project is focused on the analysis of myeloid cell associated genes and their products in bovine gamma/delta T cells. We have performed a comprehensive analysis of over 20 myeloid cell genes in sorted bovine gamma/delta T cells. Transcripts were found for all TLRs, scavenger receptors, CD11b, and a number of other genes. We have started to systematically examine the function of each of these gene products. We have now shown that bovine gamma/delta T cells express functional CD36, which is regulated by phorbol ester activation. Gamma/delta T cell CD36 facilitates TLR2 recognition of LTA, but not peptidoglycan. We have also confirmed that gamma/delta T cells express NRAMP and the MARCO scavenger receptor. Analysis of the BLIMP-1 transcription factor, which is important in the differentiation of myeloid and B cells, is also being pursued in this project. We have shown that BLIMP-1 is regulated in gamma/delta T cells and have established RNA interference techniques to downregulate BLIMP-1 transcripts in primary gamma/delta T cells as an approach to analyze its function. New antibody reagents have been generated to study BLIMP-1 protein in bovine cells.

Impacts
This novel series of experiments will shed light on common gene expression patterns in bovine myeloid cells and gamma/delta T cells. Analyses of these gene products may shed light into novel approaches to altering the function of gamma/delta, which may lead to the development of new adjuvants to enhance both innate and adpative immunity.

Publications

  • Hedges, J.F., Lubick, K., and Jutila, M.A. 2004. gd T cells respond directly to pathogen associated molecular patterns. J.Immunol. in press.
  • Graff J.C., Hedges, J.F., and Jutila, M.A. 2004. B lymphocyte-induced maturation protein-1 (Blimp-1) in gamma/delta T cells. FASEB, LB186.
  • Jutila, M., Graff, J., and Hedges, J.F. 2004. Gene Expression in bovine gd T cells. 7th International Veterinary Immunology Symposium, WK.8.6.6.
  • Lubick, K. and Jutila, M.A. 2004. Expression of CD36 on bovine gamma/delta T cells. FASEB Abstract, submitted


Progress 01/01/03 to 12/31/03

Outputs
This is a new project that follows on preliminary data generated in our functional genomic analysis of bovine gamma/delta T cells. In those studies, we found a link between gamma/delta T cells and myeloid cells, based on common gene expression patterns. The intent of this new project is to determine whether any of the "myeloid" cell gene products actually are functionally important in gamma/delta T cells. One particularly intriguing gene is BLIMP-1 which is a transcription factor that regulates myeloid cell development. BLIMP-1 mRNA is expressed in bovine gamma/delta T cells. Experiments will be done to determine if functional protein is also expressed. We have succeeded in generating a polyclonal antisera that reacts with bovine BLIMP-1 and preliminary experiments confirm BLIMP-1 protein expression in bovine gamma/delta T cells

Impacts
This novel series of experiments will shed light on common gene expression patterns in bovine myeloid cells and gamma/delta T cells. Analyses of these gene products may shed light into novel approaches to altering the function of gamma/delta, which may lead to the development of new adjuvants to enhance both innate and adpative immunity.

Publications

  • No publications reported this period